Literature DB >> 7761145

Drug-resistant malaria in children and in travelers.

D L Longworth1.   

Abstract

Malaria remains a significant cause of childhood morbidity and mortality worldwide. Drug resistance in Plasmodium falciparum has become widespread in the past 30 years, and in some parts of the world multidrug resistance is common. Chloroquine resistance in Plasmodium vivax has recently been recognized in Indonesia. The mechanisms of drug resistance have been defined for the antifolate antimalarial agents but remain incompletely understood for the quinolines. Judicious use of antimalarial compounds will be essential to prevent the emergence and spread of further drug resistance. The history, geographic distribution, and mechanisms of drug resistance are reviewed, together with current recommendations regarding prophylaxis and therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761145     DOI: 10.1016/s0031-3955(16)38983-0

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  2 in total

1.  Therapy and drug resistance in malaria.

Authors:  A V Kulkarni; L Kasturi; A Amin; V Mashankar
Journal:  Indian J Pediatr       Date:  2000-01       Impact factor: 1.967

2.  Evaluation of the OptiMAL test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malaria.

Authors:  C J Palmer; J F Lindo; W I Klaskala; J A Quesada; R Kaminsky; M K Baum; A L Ager
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.